Methanex Corp. (NASDAQ:MEOH): Dahlman Rose elevated Methanex’s price target due to revised applications growth, product price strength, and volume growth leverage. Shares are rated Buy.
Goldcorp Inc. (NYSE:GG): RBC Capital reduced its target on Godcorp following the company’s announcement of lower than hoped Q2 gold production and lowered its 2012 gold production guidance. But the firm reiterates an Outperform rating on the stock.
Johnson & Johnson (NYSE:JNJ): According to Cowen, Johnson & Johnson’s possession of Synthes ought to speed up earnings and revenue growth moving ahead. Cowen also referenced Pharma sales growth and a better looking fundamental outlook as additional motivators. Shares are rated Outperform.
KLA-Tencor Corporation (NASDAQ:KLAC): Cowen reported KLA-Tencor being its unquestionable long-term favorite in ts space after its pre-announced Q4 results. Cowen referenced better financial position, dividend yield, and solid margins. Shares are rated Outperform.
Gilead Sciences Inc. (NASDAQ:GILD): Following GlaxoSmithKline’s (NYSE:GSK) announcement of statistically superior results for its HIV drug GSK-572/Epzicom versus Gilead’s competing drug, RBC Capital notes that patients receiving Epzicom have had more heart attacks. The firm believes doctors show a preference for Gilead’s medication, and RBC holds to an Outperform rating for Gilead.
Want news like this in real-time so you can get an edge? Click here for Wall St. Cheat Sheet Pro.